Navigation Links
AGI Dermatics Presents Comparative Data That Indicates OCTN-1 Skin,Cells Have the Ability to Recognize, Transport and Utilize,L-ergothioneine (EGT) As A Protector Against Oxidative Damage

Clinical Poster Presented at Society for Investigative Dermatology

FREEPORT, N.Y., May 16, 2007 /PRNewswire/ -- AGI Dermatics recently announced new comparative clinical data that indicates that OCTN-1 skin cells have the ability to recognize, transport and utilize L-ergothioneine (EGT) as a protector against oxidative damage, and importantly, that (EGT) acts as a more powerful and efficient antioxidant than idebenone, scavenging reactive oxygen species and reducing UV-induced hydrogen peroxide (H2O2). The data was presented at the 68th Annual Meeting of the Society for Investigative Dermatology, May 9 - 12, in Los Angeles, CA.

"We are very excited that this clinical work demonstrates that OCTN-1 plays a vital role in the active accumulation and utilization of EGT for the treatment of photodamaged skin," said Daniel Yarosh, PhD, President, AGI Dermatics. "This data confirms that L-ergothioneine is a natural part of the skin's antioxidant system."

EGT is an exclusive and maximized natural amino acid that has been used in topical applications. The cellular receptor and transporter for EGT, OCTN-1 has recently been identified and is responsible for the intracellular accumulation of this naturally occurring antioxidant. However, there have been questions of the role of EGT and its receptor/transport, OCTN-1.

To examine this, the mRNA expression in cultured normal human epidermal keratinocytes (NHEK) and normal human dermal fibroblasts (NHDF) was analyzed. Results indicate OCTN-1 mRNA was detectable equally in both NHEK and NHDF with quantitative measurements by real-time PCR. To further investigate any differences in production of OCTN-1 and to assure production of OCTN-1 in both NHEK and NHDF, the study also looked at the transcription of the OCTN-1 mRNA into OCTN-1 protein. Results indicate OCTN-1 protein isoforms were more abundant in NHDF than NHEK, though still detectable in NHEK, as shown
'"/>




Page: 1 2

Related medicine technology :

1. AGI Dermatics Data Shows the 8 Oxo-Guanine Repair Enzyme OGG1 Encapsulated in Liposomes, Reduces MMP-1 and TNF-alpha in UV Irradiated Skin Cells
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
4. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
5. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
6. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
7. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
8. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
9. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
10. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
11. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein

Post Your Comments:
(Date:11/25/2009)...RINCETON,N.J.,Nov.25/PRNewswire-FirstCall/--Pharma...calcompanycommittedtodiscovering,developingandcomm...edfinancialresultsforthefiscalyearendedSeptember30...incash,cashequivalentsandshortterminvestments. ,... ,, Phase2bTrial ,, InlateNovember2009,...
(Date:11/25/2009)...RIDGEWATER,N.J.,Nov.25/PRNewswire/--TheFDAgrantedt...blets,anon-nucleosidereversetranscriptaseinhibitor...edforuseintreatment-experiencedadultswhoareexperie...NNRTIandotherantiretroviral(ARV)agents.Thetraditio...sknownasDUET-1andDUET-2.INTELENCEiscurrentlymarket...
(Date:11/25/2009)...ASKINGRIDGE,N.J.,Nov.25/PRNewswire/--RegadoBioscie...ntithromboticaptamerswithactivecontrolagents,annou...ntingatthePiperJaffray21stAnnualHealthCareConferen...resentationwillbegivenat1:10pm(EST)onTuesday,Decem...withemphasisontheleaddevelopmentprogram,theanticoa...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Encorium Announces Receipt of Letters from Nasdaq Regarding its Second Quarter 2009 Form 10 Q Filing 13726 1Encorium Announces Receipt of Letters from Nasdaq Regarding its Second Quarter 2009 Form 10 Q Filing 13726 2Encorium Announces Receipt of Letters from Nasdaq Regarding its Second Quarter 2009 Form 10 Q Filing 13726 3Boston Scientific Announces Schedule for European Society of Cardiology Congress 4909 1Boston Scientific Announces Schedule for European Society of Cardiology Congress 4909 2Boston Scientific Announces Schedule for European Society of Cardiology Congress 4909 3Boston Scientific Announces Schedule for European Society of Cardiology Congress 4909 4Boston Scientific Announces Schedule for European Society of Cardiology Congress 4909 5Boston Scientific Announces Schedule for European Society of Cardiology Congress 4909 6Steady Improvements Seen for Young Blood Cancer Patients 55572 1Steady Improvements Seen for Young Blood Cancer Patients 55572 2
...a Is Expected to Be Presented in Third Quarter -, ...daq: VIAP ), a biotechnology company focused on t...ardiovascular disease, announced today that,it has...terectomy (CEA),study, the first of three Phase 2 ...product candidate., VIA-2291 is a potent small mo...
...ch 20 Valor Medical, an emerging medical,device c...first human,implant of Neucrylate AN for treatment...akbaz at the University of Tehran. The treatment w...had been approved by the University,s,Internal Eth...t,s aneurysm was a type and location,that is very ...
Other Medicine Technology:VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 2VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 3VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 4VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial 5
(Date:11/26/2009)...thrill when on an emotional rollercoaster, study f...ws) -- Call it the fear factor meets the jubilant ...ors -- especially those who root for the winning t...losely contested match and victory was in doubt, p...Chew on that this Thanksgiving weekend as you,re g...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Cente...las , is one of a growing number of physicians who...g sites to connect with individuals who are intere...rbid obesity. Dr. Kim is utilizing Facebook to sha...is practice with the community. , ...
(Date:11/26/2009)... Benton Communications announces a highly e... for retailers struggling to make an economic reco...26, 2009 -- Flu fears is the type of challenge tha... room, according to Dr. David Benton, business gro...ss growth system – The Rfactor Intensive . ...
(Date:11/25/2009)....,Nov.25/PRNewswire-USNewswire/--Whenmostpeoplehea...actorcanalsogivepatientsthehelptheyneed.TMJstandsf...mandible)contacts/connectswithyourskull(temporalbo...ysfunctionarepainwithchewing,clickingorpoppingofth...tionincluding:headaches,fatigue,sleepdisturbances,...
(Date:11/25/2009)...,Calif.,Nov.25/PRNewswire-FirstCall/-- OnyxPharma...companywillhosttwoinvestoreventsinDecember: ,, ...10:00a.m.ET ,, Principalinvestigatorswilldisc...edand/orrefractorymultiplemyeloma,asfeaturedatthe5...dExpositioninNewOrleans,LA.Theteleconferencewillbe...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...disease is a neurodegenerative disease of the subs...sease was // first discovered and its symptoms doc... Parkinson and the associated biochemical changes ...study done recently it was seen that a drug previo...
...eight at the period of gestation has a profound ef...t has been found // that although children even if... 50% risk towards psychological distress in their ...il recently it has been unclear whether the effect...
...court hearing over nimesulide, a controversial non...dia to treat // fever and pain the health ministry...ia’s drug regulatory agency and not evaluated for ...llenging the use of nimesulide among children. The...
...feel that heart failure can be an important clinic...oblems in // the older population. In a stud... Massachusetts Medical School say that ageing popu... revealed that of the total patients studied who w...
... been used for prevention of pregnancy for decades...ver a recent study indicates that wearing a condom...ction against other sexually transmitted diseases,...o many. Current surveys indicate that approx. 12 m...
...vey on bipolar disorder conducted by the World Fed... the // disease feel that their quality of life su...der is a psychotic disorder characterized by succe...ic condition and most of the sufferers have multip...
Other Medicine News:Health News:Re –growing Brain cells destroyed by Parkinson’s disease 2Health News:Is low birth weight related to psychological distress in adulthood? 2Health News:Condoms May not be safe Enough 2
...smeter is designed for fast & easy operation. The ...ate for everyone., ,In AUTO mode, the readings...aligned. Multi-Focal lenses are automatically dete...o correctly position the lens. The color touch pan...
Pro-lll
FF 450plus Fundus Camera
TRC-50FXC
Medicine Products: